Innovation Pharmaceuticals Inc (IPIX)

[Here Today]

Hmmmm. Maybe, just Maybe.....


“Amgen on Monday detailed a series of early-stage pipeline assets it believes hold promise, including a cholesterol-targeting treatment and a potential obesity drug for heart patients.
The company also said it may take advantage of the recent selloff in biotech stocks to pursue deals in the sector.
“It’s not lost on us that the recent decline in valuations for many biotech assets could create more compelling opportunities for us,” long-time Chief Executive Robert Bradway said at the company’s business review meeting with investors.
“We have the financial strength, the flexibility to consider a wide range of possibilities.”